• Users Online: 225
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2013| January-March  | Volume 7 | Issue 1  
    Online since December 4, 2017

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Extra anatomic hepatic artery reconstruction in deceased donor liver transplantation – Feasibility and outcome
Kapileshwer Vijay, CS Naidu, Pankaj Rao, Sanjay Sharma, Rajesh Godara, Varunika Vijayvergia
January-March 2013, 7(1):6-9
DOI:10.1016/j.ijt.2013.01.002  
Background: Hepatic arterial inflow to the liver graft following liver transplantation is critical to graft survival. When recipient hepatic artery is not available due to injury or recipient hepatic artery flow is inadequate extra anatomic hepatic arterial reconstruction during deceased donor liver transplantation is required to ensure adequate hepatic arterial blood flow to the graft. The outcome in such patients is analyzed and compared with patient with standard hepatic artery reconstruction. Methods: Retrospective analysis of 30 patients who underwent Deceased Donor Liver Transplantation (DDLT) from March 2007 to May 2010 was done to assess the outcome of extra anatomic arterial inflow reconstruction. DDLT with standard end to end Hepatic Artery anastomosis performed in 24 patients (n = 24) served as control. Extra anatomic hepatic arterial reconstruction (EAHAR) was performed in 6 patients. The preferred choice of EAHAR was to fashion an infrarenal aortic conduit using stored donor iliac artery graft routed through the base of the transverse mesocolon. Results: Extra anatomic hepatic arterial reconstruction is not associated with increased morbidity, mortality, blood loss, operating room time or thrombosis. Conclusion: Extra anatomic hepatic arterial reconstructions are associated with excellent long-term outcomes and provide acceptable alternatives for arterial reconstruction.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub] [CITATIONS]
  3 331 29
CASE REPORTS
Early post-renal transplant graft segmental necrosis masquerading as vascular rejection
Gangadhar Taduri, MS Uppin, AK Prayaga, KV Dakshinamurty
January-March 2013, 7(1):17-19
DOI:10.1016/j.ijt.2013.01.004  
Vascular complications are common in immediate post renal transplant, which can be due to immunological and non-immunological causes. Major vascular events are clinically obvious which present with graft dysfunction; minor segmental defects are not clinically significant. We a report a case with segmental vascular complication secondary to perfusion related problem posing a diagnostic dilemma of vascular rejection.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 253 25
Aspergillus pneumonia in a renal transplant recipient
P Shrijjaa, VN Unni, A Mathew, R Rajesh, G Kurien
January-March 2013, 7(1):20-23
DOI:10.1016/j.ijt.2013.01.001  
Infections following renal transplantation remain a major cause of morbidity and death. Aspergillus fumigates is an invasive opportunistic fungal infection with a rapid course and grave prognosis. Early diagnosis is critical for a favourable outcome in invasive aspergillusis, but is difficult to achieve with easy methods of diagnosis; deep tissue diagnostic specimens are often difficult to obtain from critically ill patients. We report a case of cadaver donor renal allograft recipient who had a fatal pulmonary infection with rapid downhill course due to Aspergillus fumigatus.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 248 17
Cytomegalovirus associated superficial venous thrombosis in a renal allograft recipient
DS Rana, Vinant Bhargava, D Khullar, Anurag Gupta, Singh Kulwant
January-March 2013, 7(1):24-27
DOI:10.1016/j.ijt.2013.01.006  
Patient M, a 54 year old gentleman, had undergone live emotionally related renal allograft transplantation in 2004. He presented with history of swelling over both his lower limbs associated with redness and pain of 10 days duration. There was associated low-grade fever, recurrent loose stools of 10 days duration. He was found to have anemia (Hb: 10.2 mg/dL), leucocytosis (TLC: 14,200), acute graft dysfunction (Serum creatinine: 5.24 mg/dL). Venous Doppler of the lower limbs revealed thrombosis of the superficial venous system (great saphenous vein) bilaterally. His serum CMV-PCR revealed significant viral load (10,400 copies/mL). Colonoscopic biopsy revealed CMV DNA positivity on immunohistochemistry. He was managed with anticoagulation (low molecular weight heparin for 3 weeks adjusted to the renal dysfunction), antibiotics and intravenous ganciclovir (for 2 weeks). Thereafter, he recieved oral valganciclovir for another 10 weeks. Swelling in the lower limb and pain reduced after 3 weeks and serum CMV-PCR revealed undetectable viral copies after 4 weeks of therapy. Repeat venous doppler for venous thrombosis after 4 weeks revealed recanalised superficial venous system. We attribute the present episode of superficial vein lower limb thrombosis involving both his lower limbs to cytomegalovirus.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 308 25
Clinical research on immunosuppressive drugs: The impact of new proposed organ donation guidelines
Mohammed Imran
January-March 2013, 7(1):28-30
DOI:10.1016/j.ijt.2012.11.001  
The release of National Institute of Health and Clinical Excellence guidelines for improving donor identification and consent rates and British Medical Association opinion regarding reintroduction of concept of ‘Elective Ventilation’ has started the debate in the realm of medical ethics. The concept of elective ventilation was earlier introduced by Royal Devon & Exeter Hospital in 1988 and finally declared unlawful by the Department of Health, United Kingdom in 1994 when ethical concerns were raised by the medical fraternity. Growth and development of safer and effective immunosuppressive drugs is hooked to the optimum number of cases of organ transplantation in research protocol. Toxic profile of these drugs and poor compliance has decreased their effectiveness. The drug discovery and development of safer immunosuppressants has been quite sluggish especially in last two decades. Very few randomised clinical trials have been performed in children and lesser subjects are being enrolled even in adult organ transplant clinical research. Without optimum number of clinical trial participants, it is difficult to extrapolate finding on larger population thus resulting in region specific divergent treatment protocols. Introduction of improved organ donation guidelines will enhance the number of cases of immunosuppressants used.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 228 18
Role of interventional management in post transplant ureteric stricture: Case report & review of literature
Hira Lal, Anuj Thakral, Alok Kumar, Anshul Jain, Narayan Prasad, Anupama Kaul, Dharmendera Bhadauria, Amit Gupta, RK Sharma, Anish Srivastava, PK Pradhan
January-March 2013, 7(1):31-35
DOI:10.1016/j.ijt.2013.01.005  
Kidney transplantation is the treatment of choice employed the world over for end stage kidney disease. Anastomotic leakage and stricture formation at site of ureterovesical anastomosis complicates 3–9% of all renal transplants and are the commonest complications encountered with the practice of renal transplantation. Patients with urinary anastomotic complications require significantly longer and more frequent hospitalization. There is also higher incidence of urinary tract and non-urinary tract infections with greater risk of developing acute renal failure. We report a case of an allograft renal transplant recipient who presented with recurrent episodes of transplant kidney hydronephrosis and was diagnosed with ureteric stricture 10 years post transplant. Detailed percutaneous interventional management of post transplant ureteric stricture has been described here.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 250 26
EDITORIAL
Editorial
RK Sharma
January-March 2013, 7(1):1-1
DOI:10.1016/j.ijt.2013.03.001  
Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 194 34
LITERATURE REVIEW
Help patients undergo kidney transplantation: Medical social worker/transplant co-ordinator's perspective
Sujata Rajapurkar
January-March 2013, 7(1):10-16
DOI:10.1016/j.ijt.2012.11.002  
End Stage Renal Disease (ESRD) can be successfully treated with maintenance dialysis and/or kidney transplantation giving good quality & good length of life to these patients. However these life saving treatments are beyond the resources of majority of our population and also beyond the Government's ability to provide. Moreover those who undergo kidney transplantation a lot of legal documentation requires to be done. Professionally trained medical social workers (MSW) employed in hospitals are now also trained in transplant co-ordination. Most people believe that anyone can do “Social Work” as the term is used commonly but a professionally well trained MSW makes a big difference to the success of a unit managing patients with ESRD. The chronic nature of ESRD & its required treatment provides renal patients with multiple disease related and treatment related psychosocial stressors that affect their everyday lives.1 MSW are an important component of multidisciplinary team of professionals needed for adequate delivery of care to these patients to cope with the disease and its' therapy. They help to improve outcome, ameliorate psychosocial barriers to ESRD care such as: adjustment & coping to the illness & treatment, medical complications and problems, social role adjustment: familial, social, and vocational, concrete needs: financial loss & insurance coverage, appetite, freedom with diet and fluid. MSW can help by providing counseling and coordination between team members and between professionals and patients. They are the powerful patient advocates with the highly qualified physicians, surgeons and all other regulatory authorities. All these activities lead to better disease outcome & improved quality of life (QOL).2
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 267 34
ORIGINAL ARTICLES
Is the ureter to the kidney the same as the bile duct to the liver? A perspective from the cadaveric donor
Vitali Mezentsev, David Rix, Naeem Soomro, David Talbot
January-March 2013, 7(1):2-5
DOI:10.1016/j.ijt.2013.01.003  
Objectives: Both the ureter and bile duct are vulnerable during transplantation. The aim of this study was to compare ureteric and bile duct complications following kidney and liver transplant respectively. Methods: We analysed the rate of urological complications in 423 renal transplant operations performed on 419 patients in our unit from 2007 till 2011. The donor source was after brain death – DBD, after cardiac death – DCD and live donors. 138 liver transplants from cadaveric donors were reviewed for biliary complications. In live donors kidneys were procured laparoscopically. Results: In the kidney group there was a urological complication rate of 4.2% in recipients from deceased donor and 3.6% from living donors. The difference between the rate of ureteric complications from deceased and living donors was not statistically significant. In 138 liver recipients with duct to duct anastomotic technique 29 developed bile duct complications (21%). The difference between the rate of bile duct strictures between DCDs and DBDs was not statistically significant. Conclusion: The rate of bile duct complications in cadaveric liver recipients was significantly higher than the rate of ureteric strictures in kidney recipients, p < 0.01. Biliary strictures were often multiple and longer than ureteric strictures.
[ABSTRACT]   Full text not available  [PDF]  [Mobile Full text]  [EPub]
  - 289 26